Highlights
NASDAQ: EIGR       Eiger Biopharma
Last Price Today's Change   Day's Range   Trading Volume
13.95   +0.25 (1.82%)  13.45 - 15.20  413,300

Overview

 
Avg Volume (4 weeks):259,952
4 Weeks Range:8.20 - 18.00
4 Weeks Price Volatility (%):
58.67%
52 Weeks Range:6.10 - 18.00
52 Weeks Price Volatility (%):
65.97%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Eiger BioPharmaceuticals Inc is a clinical stage biopharmaceutical company. It is focused on bringing to market novel product candidates for the treatment of orphan diseases. The company’s pipeline includes five Phase 2 development programs addressing four distinct orphan diseases. The pipeline includes lonafarnib for Hepatitis Delta Virus, or HDV, PEG-interferon lambda-1a (lambda) for HDV, exendin 9-39 for Post-Bariatric Hypoglycemia, or PBH and ubenimex for Pulmonary Arterial Hypertension, or PAH and lymphedema.

  Be the first to like this.
 


 

4922  2695  853  90 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 GE 14.18-1.11 
 NVCN 0.04+0.004 
 BAC 30.44-0.45 
 EEM 46.49-0.02 
 CHK 4.64+0.10 
 SPY 273.36+0.75 
 MU 59.97+0.94 
 HPE 15.58-1.83 
 AVGR 2.23+0.94 
 XLF 28.16-0.18 
Partners & Brokers